Evidence map›Paper›PMID 33771991›Full record

ArticleNature communications2021

Single-cell analyses of Crohn's disease tissues reveal intestinal intraepithelial T cells heterogeneity and altered subset distributions.

Natalia Jaeger, Ramya Gamini, Marina Cella, Jorge L Schettini, Mattia Bugatti, Shanrong Zhao, Charles V Rosadini, Ekaterina Esaulova, Blanda Di Luccia, Baylee Kinnett and 6 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 145 papers.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 228 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. CD8MedComm · 2026
    Review
  9. Article
  10. The roles and heterogeneity of CD8International journal of molecular medicine · 2026
    Review
  11. Article
  12. Article
  13. Dissecting PGENature communications · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Natalia Jaeger *Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Ramya Gamini *Pfizer Worldwide Research, Development and Medical, Cambridge, MA, USA.ORCID 0000-0002-9205-9792
Marina Cella *Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0003-1230-1313
Jorge L SchettiniPfizer Worldwide Research, Development and Medical, Cambridge, MA, USA.ORCID 0000-0002-3089-7918
Mattia BugattiDepartment of Pathology, University of Brescia, Brescia, Italy.
Shanrong ZhaoPfizer Worldwide Research, Development and Medical, Cambridge, MA, USA.
Charles V RosadiniPfizer Worldwide Research, Development and Medical, Cambridge, MA, USA.
Ekaterina EsaulovaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0001-9806-662X
Blanda Di LucciaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.
Baylee KinnettDivision of Gastroenterology, Washington University School of Medicine, St Louis, MO, USA.
William VermiDepartment of Pathology, University of Brescia, Brescia, Italy.ORCID 0000-0002-2291-2997
Maxim N ArtyomovDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0002-1133-4212
Thomas A WynnPfizer Worldwide Research, Development and Medical, Cambridge, MA, USA.
Ramnik J XavierImmunology Program, Infectious Disease and Microbiome Program, Broad Institute of MIT, Cambridge, MA, USA.ORCID 0000-0002-5630-5167
Scott A JelinskyPfizer Worldwide Research, Development and Medical, Cambridge, MA, USA.ORCID 0000-0002-5114-0236
Marco ColonnaDepartment of Pathology and Immunology, Washington University School of Medicine, St Louis, MO, USA. mcolonna@wustl.edu.ORCID 0000-0001-5222-4987
Washington University in St. Louis · USPfizer (United States) · USUniversity of Brescia · ITBroad Institute · USWashington State University Vancouver · US

Funding

WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
Technology Development Project - Increasing the complexity of ex vivo human airway models for studying immune response to viral infectionU19AI142733 · NIAID · JACKSON LABORATORY · PI Anna Karolina Palucka · 2019 to 2026
$23.1M
Mucosal Immune Defense Mechanisms of the Urinary BladderU01AI095542 · NIAID · WASHINGTON UNIVERSITY · PI COLONNA, MARCO, HULTGREN, SCOTT J. · 2011 to 2020
$9.8M
Systematic dissection of gut cellular circuits [at single cell resolution]RC2DK114784 · NIDDK · BROAD INSTITUTE, INC. · PI ASHENBERG, ORR, GRAHAM, DANIEL BARTHOLOMEW · 2017 to 2021
$9.0M
Washington University Rheumatic DiseasesResearch Resource-based CenterP30AR073752 · NIAMS · WASHINGTON UNIVERSITY · PI Alfred Hyoungju Kim · 2018 to 2026
$7.6M
CIS-REGULATORY CIRCUITS FOR ILC FUNCTION AND PLASTICITYR01AI134035 · NIAID · WASHINGTON UNIVERSITY · PI MARCO COLONNA, Eugene M Oltz · 2018 to 2026
$4.8M
The role of TGFbeta in development and function of salivary gland innate lymphoid cellsR01DE025884 · NIDCR · WASHINGTON UNIVERSITY · PI COLONNA, MARCO, WEISMAN, GARY ANDREW · 2017 to 2021
$3.5M
Plasticity of Innate Lymphoid Cells: Mechanisms and Biological ImpactR01DK124699 · NIDDK · WASHINGTON UNIVERSITY · PI COLONNA, MARCO · 2020 to 2023
$1.4M
NCATS NIH HHS UL1 TR002345NIAID NIH HHS R01 AI134035NIAID NIH HHS U01 AI095542NIAID NIH HHS U19 AI142733NIAMS NIH HHS P30 AR073752NIDCR NIH HHS R01 DE025884NIDDK NIH HHS P30 DK043351NIDDK NIH HHS P30 DK052574NIDDK NIH HHS R01 DK124699NIDDK NIH HHS RC2 DK114784
6 · The paper itself

Abstract

Crohn's disease (CD) is a chronic transmural inflammation of intestinal segments caused by dysregulated interaction between microbiome and gut immune system. Here, we profile, via multiple single-cell technologies, T cells purified from the intestinal epithelium and lamina propria (LP) from terminal ileum resections of adult severe CD cases. We find that intraepithelial lymphocytes (IEL) contain several unique T cell subsets, including NKp30

Indexed as

CD4-Positive T-LymphocytesCD8-Positive T-LymphocytesCells, CulturedCrohn DiseaseGene Expression ProfilingHumansIntraepithelial LymphocytesLymphocyte CountSingle-Cell AnalysisTh17 CellsT-Lymphocytes, RegulatoryT-Lymphocyte Subsets

Identifiers

PMID33771991
PMCPMC7997960
OpenAlexW3137742875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.